Mohammad Ahangari

Mohammad Ahangari

Auto-generated profile, based on publicly available information

Mohammad Ahangari

Herasight Research, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in TURKISH JOURNAL OF CHEMISTRY
Verified
Journal Article
Open access
PDF file
MAMohammad Ahangari
Mohammad Ahangari
EMElham Mahmoodi
Elham Mahmoodi
NDNagi̇hAn Deli̇bAş
Nagi̇hAn Deli̇bAş
JMJafar Mostafaei
Jafar Mostafaei
EAElnaz Asghari
Elnaz Asghari
ANAligholi Niaei
Aligholi Niaei
Energy storage by supercapacitors with short charging time and high power density is one of the types of electrochemical storage systems. Perovskite oxides have been significantly investigated as promising materials for energy storage in electrochemical systems. In this study, three perovskites, SrFeO3, SrCoO3, and SrCo0.5Fe0.5O3, were prepared using the sol-gel method and used as supercapacitor electrode materials. In fact, in this research, two consecutive elements (Fe, Co) from the periodic table that differ by one unit in atomic number are placed in the perovskite structure to study their electrochemical properties for use in supercapacitors. From the obtained results, it was found that Co doping with a ratio of 1/1 (Co/Fe) at B site of SrFeO3 reduced the specific capacitance from 101.687 F g-1 to 60.912 F g-1 at a scan rate of 10 mV s-1. Also, the specific capacitance of SrCoO3 decreased from 68.639 F g-1 to 60.912 F g-1 at the same substitution rate at B site.

27 September 2023 in Electrochimica Acta
Verified
Journal Article
Closed access
MAMohammad Ahangari
Mohammad Ahangari
JMJafar Mostafaei
Jafar Mostafaei
HZHamid Zakerifar
Hamid Zakerifar
ASAli Sayyah
Ali Sayyah
NDNagihan Delibaş
Nagihan Delibaş
ANAligholi Niaei
Aligholi Niaei

29 September 2023 in Journal of Cleaner Production
Verified
Journal Article
Closed access
ASAli Sayyah
Ali Sayyah
MAMohammad Ahangari
Mohammad Ahangari
JMJafar Mostafaei
Jafar Mostafaei
SNSeyed Reza Nabavi
Seyed Reza Nabavi
ANAligholi Niaei
Aligholi Niaei

16 May 2025 in Electrochimica Acta
Verified
Journal Article
Closed access
MAMohammad Ahangari
Mohammad Ahangari
JMJafar Mostafaei
Jafar Mostafaei
HEHamid Erfan-Niya
Hamid Erfan-Niya
NDNagihan Delibaş
Nagihan Delibaş
EAElnaz Asghari
Elnaz Asghari
ANAligholi Niaei
Aligholi Niaei

8 August 2025 in medRxiv
Verified
Preprint
Open access
PDF file
SMSpencer Moore
Spencer Moore
IDIvan Davidson
Ivan Davidson
JAJonathan Anomaly
Jonathan Anomaly
JLJeremiah Li
Jeremiah Li
MAMohammad Ahangari
Mohammad Ahangari
TWTobias Wolfram
Tobias Wolfram
The clinical implementation of polygenic scores (PGSs) for disease risk prediction, particularly in reproductive health applications, requires rigorous validation. Here, we develop seventeen disease PGSs by conducting large-scale GWAS meta-analyses, and we validate our scores in out-of-sample prediction analyses. We achieve state-of-the-art predictive performance, consistently matching or outperforming academic and commercial benchmarks, with liability R 2 reaching up to 0.21 (type 2 diabetes). The performance of a PGS for embryo screening depends on its predictive ability within-family, which can be lower than its prediction ability among unrelated individuals. However, very few disease PGSs have been tested within-family. We perform systematic within-family validation of our disease PGSs, finding no decrease in predictive performance within-family for 16 of 17 scores. PGS performance typically declines with genetic distance from training data, an effect that needs to be accounted for to give properly calibrated predictions across ancestries. We perform extensive calibration of our scores’ performance across different ancestries, finding improved cross-ancestry performance compared to previous approaches, especially in African and East Asian populations. This is likely due to the fact our scores are constructed using a method that incorporates functional genomic annotations on more than 7 million variants, enabling a degree of fine-mapping of causal variants shared across ancestries. We illustrate clinical utility through examining the risk reduction that could be achieved through embryo screening for type 2 diabetes: selecting among 10 embryos is expected to reduce absolute disease risk by 12-20% in families where both parents are affected, with similar relative risk reductions across ancestries. These findings establish a framework for implementing PGS in reproductive medicine while demonstrating both the technology’s potential for disease prevention and the methodological standards required for responsible clinical translation.

14 July 2025 in medRxiv
Verified
Preprint
Open access
PDF file
WEWorrawat Engchuan
Worrawat Engchuan
OSOmar Shanta
Omar Shanta
KKKuldeep Kumar
Kuldeep Kumar
JMJeffrey R. MacDonald
Jeffrey R. MacDonald
BTBhooma Thiruvahindrapuram
Bhooma Thiruvahindrapuram
JSJonathan Sebat
Jonathan Sebat
Psychiatric conditions share common genes, but mechanisms that differentiate diagnoses remain unclear. We present a multidimensional framework for functional analysis of rare copy number variants (CNVs) across 6 diagnostic categories, including schizophrenia (SCZ), autism (ASD), bipolar disorder (BD), depression (MDD), PTSD, and ADHD (N = 574,965). Using gene-set burden analysis (GSBA), we tested duplication (DUP) and deletion (DEL) burden across 2,645 functional gene sets defined by the intersections of pathways, cell types, and cortical regions. While diagnoses converge on shared pathways, mixed-effects modeling revealed divergence of pathway effects by cell type, brain region, and gene dosage. Factor analysis identified latent dimensions aligned with clinical axes. A primary factor (F1) captured reciprocal dose-dependent effects of DUP and DEL in SCZ reflecting positive and negative effects in excitatory versus inhibitory neurons and association versus sensory cortex. SCZ and ASD were both strongly aligned with F1 but with opposing directionalities. Orthogonal factors highlighted neuronal versus non-neuronal effects in mood disorders (F2) and differential spatial distributions of DEL effects in ADHD and MDD (F3). High-impact CNVs at 16p11.2 and 22q11.2 were enriched for combinations of cell-type-specific genes involved in pathways consistent with our broader findings. These results reveal molecular and cellular mechanisms that are broadly shared across psychiatric traits but differ between diagnostic categories in context and directionality.